Filing Details
- Accession Number:
- 0001012975-15-000074
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-30 14:15:55
- Reporting Period:
- 2015-01-28
- Filing Date:
- 2015-01-30
- Accepted Time:
- 2015-01-30 14:15:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1454189 | Auspex Pharmaceuticals Inc. | ASPX | Pharmaceutical Preparations (2834) | 954862842 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1512058 | Alex Zisson | 45 South Seventh Street Suite 3060 Minneapolis MN 55402 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-01-28 | 730,000 | $53.11 | 4,835,731 | No | 4 | S | Indirect | see footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | see footnote |
Footnotes
- The securities were sold to the underwriter by the Reporting Persons in connection with a secondary offering of the Issuer's securities as follows: 719,780 shares by Thomas, McNerney & Partners II, L.P. ("TMP II"), 7,519 shares by TMP Nominee II, LLC ("TMPN II") and 2,701shares by TMP Associates II, L.P. ("TMPA II").
- Includes 4,768,041 shares held in the name of TMP II; 49,805 shares held in the name of TMPN II; and 17,885 shares held in the name of TMPA II.
- The securities are held in the name of TMP II, TMPN II and TMPA II. Thomas, McNerney & Partners II, LLC ("TMP II LLC") is the general partner of TMP II and TMPA II. Alex Zisson is a manager of TMP II LLC and has shared voting and dispositive power over the securities held by TMP II and TMPA II, but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.